Home / GLP-1 appeals / Ozempic / Kaiser Permanente

Ozempic denial · Kaiser Permanente

Kaiser denied your Ozempic. Here is how to appeal it.

Most Kaiser GLP-1 denials are winnable, if your appeal speaks to Kaiser's own clinical criteria and lands before the deadline. We draft it for free, grounded in Kaiser's actual coverage rules with every citation verified. You review, sign, and file it.

Check my Kaiser denial, free See the strategy

Free to draft. Every citation checked against Kaiser's policy before you file.

Your deadline

Often 180 days

For Kaiser's first internal grievance. Some plans allow 60. Kaiser is regional, your denial notice controls, check it.

Most common reason

Off-label for weight loss

Ozempic is approved for type 2 diabetes. Used for weight loss, it is often denied or sent to step therapy.

What wins

External review

In California, an Independent Medical Review through the DMHC is free, fast, and has high overturn rates.

Why Kaiser denies Ozempic

Ozempic (semaglutide) is FDA-approved to improve blood sugar in adults with type 2 diabetes, and to reduce cardiovascular risk in adults with type 2 diabetes and known heart disease. It is not FDA-approved for weight loss; that is Wegovy. That distinction drives most Kaiser denials, alongside Kaiser's integrated HMO process. The common patterns:

  • Prescribed off-label for weight loss. When Ozempic is requested without a type 2 diabetes diagnosis, Kaiser commonly denies it as not covered for that use. If you do have type 2 diabetes, the fix is often making sure the diagnosis and A1c are clearly documented.
  • Step therapy (metformin first). Many Kaiser plans require a documented trial of metformin or another preferred agent before a GLP-1. If your records do not show the trial or a documented intolerance, the claim is denied even when that history exists.
  • Medical necessity, under Kaiser's own criteria. Kaiser's medical directors, who are Kaiser physicians, decide whether the request meets Kaiser's clinical criteria. A strong appeal answers those criteria point by point.
  • Referral or prior authorization. Kaiser's closed HMO model typically requires referral and authorization through a Kaiser physician. A missing step in that process can trigger a denial.

How to win the appeal with Kaiser

The pattern that works against Kaiser is to answer its clinical criteria directly, lead with the FDA-approved use, then use your external review rights, which in California are unusually strong.

The move: if you have type 2 diabetes, lead with that diagnosis and your A1c, since that is the indication Ozempic is approved for. File the internal grievance answering Kaiser's clinical criteria with your records, and know your external review right. In California, members generally need to complete only one internal grievance level before requesting an Independent Medical Review through the Department of Managed Health Care, which is free, typically fast, and has high overturn rates.

  • Document the type 2 diabetes diagnosis clearly: the diagnosis code, recent A1c, and treatment history. This is the FDA-approved indication and the strongest footing.
  • Answer step therapy head-on: show the prior trial of metformin or other preferred agents, with dates, or document the contraindication or intolerance that justifies skipping it.
  • Use the external review. In California, after one internal grievance you can request an Independent Medical Review through the DMHC. It is free, generally fast, and the reviewers are independent of Kaiser. Other states have their own external review process.
  • File within the window. Kaiser's internal grievance is commonly due within 180 days of the denial, though some plans allow 60. Use the exact deadline and contacts on your regional denial notice.

Sources include Kaiser's published clinical review criteria and your state's external review rights and the Ozempic prescribing information. We cite the specific policy that applies to your plan when we build your appeal.

The magic is visible

Your appeal, built from Kaiser's own rules. Every citation checked.

We draft from the sources below, then verify each one before you file. On our held-out testing: 0 invented citations, versus about 1 in 4 for raw AI.

  • Kaiser's coverage policyThe specific Kaiser clinical review criteria and formulary rules that apply to your planVerified
  • FDA labelSemaglutide (Ozempic) prescribing information, type 2 diabetes indication and dosingVerified
  • Your recordsYour diabetes diagnosis, A1c, and prior therapies, cited back accuratelyVerified

Let's check your Kaiser denial, free.

Answer a few questions for an honest read on your odds, then your verified draft. No account, no cost.

Check my denial, free

Kaiser + Ozempic: common questions

How long do I have to appeal?
Kaiser's first internal grievance is commonly due within 180 days of the denial, though some plans allow 60. Kaiser operates as regional entities, so your denial notice states the deadline and contacts that apply to you, and that controls. File as early as you can.
It was denied as off-label, can I still appeal?
Yes. If you have type 2 diabetes, the appeal centers on documenting that diagnosis and your A1c, since that is Ozempic's FDA-approved use. If it was prescribed purely for weight loss, the approved weight-management drug is a different product, and we will give you an honest read on the path.
What is an Independent Medical Review?
In California, an Independent Medical Review (IMR) through the Department of Managed Health Care lets an independent reviewer, not Kaiser, decide your case. It is free, generally fast, and in California you usually need to complete only one internal grievance level first. Other states have their own external review process.
Is this really free?
Yes. We draft your appeal for free and you file it. No fee, no contingency, nothing taken from coverage you win. AppealIt is not a law firm and does not provide legal or medical advice.

Other Ozempic appeals: Aetna · Humana · UnitedHealthcare · All Ozempic denials